Inhibition of Tau protein aggregation by rhodanine-based compounds solubilized 
via specific formulation additives to improve bioavailability and cell viability

Pickhardt, M.; Lawatscheck, C.; Börner, H. G.; Mandelkow, Eckhard

doi:doi: 10.2174/1567205014666170202103136

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Inhibition of Tau protein aggregation by rhodanine-based compounds solubilized via specific formulation additives to improve bioavailability and cell viability

MPS-Authors

/persons/resource/persons94203

Mandelkow, Eckhard
Neuronal Cytoskeleton and Alzheimer's Disease, Cooperations, Center of Advanced European Studies and Research (caesar), Max Planck Society;

External Resource

http://www.eurekaselect.com/149699/article
(Publisher version)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Pickhardt, M., Lawatscheck, C., Börner, H. G., & Mandelkow, E. (2017). Inhibition of Tau protein aggregation by rhodanine-based compounds solubilized via specific formulation additives to improve bioavailability and cell viability. Current Alzheimer Research, 14(7), 742-752. doi: doi: 10.2174/1567205014666170202103136.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002D-8CE2-2

Abstract

There is no abstract available